Aerospace Test Partnership And DoD Win Could Be A Game Changer For Curtiss-Wright (CW)

Curtiss-Wright Corporation -0.30%

Curtiss-Wright Corporation

CW

694.88

-0.30%

  • Averna recently announced it partnered with Curtiss-Wright to develop five custom aerospace test systems that integrate secure data management and Curtiss-Wright’s manufacturing execution systems to meet stringent performance and safety requirements.
  • Separately, CCC disclosed a 4-year U.S. Department of Defense contract for Curtiss-Wright’s RAST shipboard helicopter handling systems, highlighting the company’s role in advanced, safety-critical defense operations.
  • We’ll now examine how this expanded aerospace testing collaboration shapes Curtiss-Wright’s investment narrative, especially its exposure to high-specification defense technologies.

Capitalize on the AI infrastructure supercycle with our selection of the 35 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Curtiss-Wright Investment Narrative Recap

To own Curtiss-Wright today, you have to believe its exposure to high-spec defense and nuclear programs can support continued earnings growth despite valuation and contract timing risks. The Averna test-systems partnership and the new U.S. DoD RAST award both reinforce its positioning in safety critical aerospace and naval platforms, but they do not materially change the near term catalysts or the key risk around dependence on large, timing sensitive defense budgets.

The 4 year U.S. DoD contract for Curtiss-Wright’s RAST helicopter handling systems is the most relevant backdrop to this aerospace testing news. Together, they underscore how much of the thesis rests on Curtiss-Wright continuing to win and execute complex defense programs, while investors weigh whether high expectations for future growth and margins leave limited room for disappointment.

Yet behind this strong contract momentum, one risk investors should be aware of is...

Curtiss-Wright's narrative projects $4.0 billion revenue and $593.3 million earnings by 2028. This requires 6.8% yearly revenue growth and about a $141.9 million earnings increase from $451.4 million today.

Uncover how Curtiss-Wright's forecasts yield a $608.17 fair value, a 10% downside to its current price.

Exploring Other Perspectives

CW 1-Year Stock Price Chart
CW 1-Year Stock Price Chart

While consensus sees steady progress, the most pessimistic analysts were only assuming about US$3.9 billion of revenue and US$565.9 million of earnings by 2028, so this kind of aerospace and naval contract flow could either challenge or reinforce that cautious view depending on how it filters into future orders and margins.

Explore 5 other fair value estimates on Curtiss-Wright - why the stock might be worth 40% less than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Curtiss-Wright research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free Curtiss-Wright research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Curtiss-Wright's overall financial health at a glance.

Curious About Other Options?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

  • AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • We've uncovered the 14 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
  • Invest in the nuclear renaissance through our list of 85 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.